Unpack and Explore Tours offer a different way to experience sought-after destinations across the globe

DENVER, Oct. 7, 2026 /PRNewswire/ -- This is touring, but different. Unpack and Explore Tours from Globus & Cosmos invite guests to explore further, connect deeper and uncover more, while staying in one place and experiencing the best of the surrounding region.

The tours allow guests to unpack, settle in and make themselves at home in a destination, enjoying a range of included sightseeing and day trips while staying in just one or two hotels. By spending multiple nights in one destination, guests can experience a place fully and enjoy a great sense of connection to local life - all with the reassurance, expert planning and stress-free travel that comes with a Globus or Cosmos tour.

Unpack once. Explore more.

Globus & Cosmos Unpack and Explore Tours give travelers a comfortable base from which to discover not only a destination's best-known sights, but also the culture, cuisine, landscapes and lesser-known gems of the area.

From the waterfront cafés and historic streets of Split to the canals of Venice, the flavors of Rome and the musical heritage of Nashville and Memphis, each itinerary is designed to allow guests to fully experience a destination.

Alongside included sightseeing and experiences, there is plenty of free time to wander, linger over lunch, revisit a favorite spot or make discoveries independently. And with Globus and Cosmos Tour Directors and Local Guides on hand to share their knowledge and recommendations, guests can make the most of every day without having to organize all the details themselves.

"Travelers are moving beyond checklist sightseeing in favor of experiences that offer a deeper, more meaningful connection to a destination," said Scott Nisbet, President and CEO of the Globus family of brands. "Our Unpack and Explore Tours combine the convenience of expertly planned travel with the flexibility to enjoy built-in free time, local discoveries and insider recommendations from our Tour Directors and Local Guides. It's about giving travelers the opportunity to settle in, explore further and experience more of what makes a destination special."

Globus & Cosmos Unpack and Explore Tours are available across Europe and North America, with featured tours including:

- Algarve Explorer – Seven days / six nights based in Lagos, providing a gateway to Portugal's spectacular Algarve region, from $2,099 per person*. Price based on departure on May 4, 2027.

- Trieste, Venice & Slovenia Explorer – Seven days / six nights in Trieste, perfectly positioned for exploring this fascinating corner of Europe, including Venice and neighboring Slovenia, from $2,599 per person*. Price based on departure on August 27, 2027.

- Split & Dalmatian Coast Explorer – Seven days / six nights in Split, with time to discover the city and the beautiful Croatian coastline beyond, from $2,699 per person*. Priced based on departure on September 26, 2027.

- London & Country – Seven days / six nights based in London, combining the sights of the capital with opportunities to venture beyond the city, from $2,379 per person*. Priced based on departure on August 15, 2027.

- Music Cities: Nashville & Memphis – Seven days / six nights to enjoy a journey into the musical heart of America, combining two legendary cities, from $3,279 per person*. Price based on departure on May 7, 2027.

- Winter in Montréal and Québec – Six days / five nights in the winter wonderland of Canada's festive atmosphere from $3,329 per person*. Price based on departure on December 2, 2027.

- Gourmet Rome – Eight days / seven nights in the Italian capital, giving guests time to delve deeper into Rome and its celebrated food culture, from $2,399 per person*. Priced based on departure on August 29, 2027.

With fewer hotel changes, more time to explore and the freedom to experience destinations at a more relaxed pace, Globus & Cosmos Unpack and Explore Tours offer a different take on touring: unpack, settle in and discover more.

ABOUT THE GLOBUS FAMILY OF BRANDS

With nearly a century of expertise, the Globus family of brands (Globus, Cosmos and Avalon Waterways) has inspired wanderlust and made the world more accessible through a diverse portfolio of guided tours, river cruises and independent travel packages. As the world's largest tour operator, the Globus family of brands enriches lives through the joy of travel, creating extraordinary journeys that blend effortless exploration, incredible value and authentic discoveries.

SOURCE Globus family of brands

Share this article

ARMONK, N.Y., Oct. 7, 2026 /PRNewswire/ -- IBM (NYSE: IBM) will hold its quarterly conference call to discuss its third-quarter 2026 financial results on Wednesday, October 21, 2026 at 5:00 p.m. ET. The live webcast of the earnings call can be accessed at www.ibm.com/investor.

Please also visit the investor website for the earnings press release prior to the webcast. A replay, associated charts and prepared remarks will be available after the event.

Media contact:

Timothy Davidson

tfdavids@us.ibm.com 

914-844-7847

SOURCE IBM

Share this article

SAN LUIS OBISPO, Calif., Oct. 7, 2026 /PRNewswire/ -- Gateworks Corporation, an Ezurio company, today announces the GW16170, a high-power, long-range, 900MHz 802.11ah, M.2 2230 E-Key Wi-Fi radio designed to provide Wi-Fi HaLow wireless communication utilizing Gateworks single board computers (SBCs). Built with the Morse Micro MM8108-M20-US module, the USA-made GW16170 delivers up to +27.5 dBm of transmit power, extending range and wall/foliage penetration well beyond standard Wi-Fi HaLow deployments. This higher-power profile reduces the number of access points needed for large sites and strengthens link reliability for North American Industrial IoT and Edge AI deployments operating in demanding RF environments.

Engineers can integrate the GW16170 as a drop-in solution with any single board computer featuring a standard M.2 E-Key socket. It operates plug-and-play with Gateworks' SBCs based on NXP Semiconductors' i.MX 8M Mini, 8M Plus and i.MX 95 processors, including the Venice, VeniceFLEX and Catalina families. Together, these platforms create a powerful, scalable foundation for long-range wireless connectivity and edge computing across advanced industrial, autonomous and edge AI-driven systems.

"Our partnership with Morse Micro is critical to delivering complete, high-performance wireless solutions to the industrial market," says Kelly Peralta, Vice President of Sales & Business Development, Gateworks Corporation. "The GW16170 gives system integrators a high-power option purpose-built for North America's toughest coverage challenges — the kind of range and reliability that used to require cellular or costly proprietary radios."

Scaling IoT connectivity across a large physical footprint has become a core challenge for site owners, with many looking for ways to reduce the number of access points needed to get full coverage. The Gateworks GW16170 addresses this directly with a high-power variant engineered for North America's 902–928 MHz license-exempt band. Operating at sub-GHz frequencies inherently improves range and penetration through walls, floors and foliage compared to conventional 2.4/5 GHz Wi-Fi, and the GW16170's elevated transmit power extends that link budget even further — making it practical to cover expansive campuses, yards and outdoor sites with far less infrastructure.

"The GW16170, powered by our MM8108-M20 module, shows how Wi-Fi HaLow continues to mature to meet the industrial sector's toughest range and reliability requirements," says Michael De Nil, CEO and Cofounder, Morse Micro. "Gateworks is ensuring system integrators have access to a high-power, long-range solution for their most demanding outdoor and industrial deployments."

The GW16170 delivers data rates up to 43.3 Mbps, supports over 100 connected clients per access point, and maintains uninterrupted data flow for mission-critical applications such as smart transportation, smart energy, and smart city & security.

The GW16170 supports access point and station mode, WPA2-PSK/WPA3-SAE/WPA3-OWE security, and standard Linux IP networking — allowing developers to integrate it with familiar tools and no proprietary SDKs. It is FCC certified for use in North America; customers deploying in Europe should use the companion GW16167.

The GW16170 is available now through Gateworks and authorized channel partners.

About Gateworks, an Ezurio Company

Gateworks designs and manufactures high-quality, NXP® Semiconductors Arm®-based single board computers (SBCs) and wireless solutions for industrial embedded applications. Their SBCs are the preferred platform for companies who value reliability, extended product lifecycles, exceptional technical support and USA-made quality. Gateworks maintains an AS9100D/ISO 9001:2015 certified quality management system to ensure all products meet the highest standards of dependability. All our products are engineered and manufactured at our corporate headquarters in San Luis Obispo, California, established in 1998.

From smart factories to transportation, drones to IoT gateways, Gateworks will help get your project to market quickly.

For more information, please contact:

Jordan Manser, Sr. Marketing Manager

Phone: +1 330 259 5943

Email: [email protected]

SOURCE Ezurio

Share this article

Secure, centrally managed dashboard apps bring business data to the TVs teams already look at.

HOUSTON, Oct. 7, 2026 /PRNewswire/ -- OptiSigns, a digital signage company powering more than 200,000 screens worldwide, today announced expanded and enhanced dashboard apps, which now work with Microsoft Power BI, Salesforce, Tableau, Grafana, Databricks and more. Businesses can now show automatically updating live dashboards on TV screens in offices, factories and operations centers.

Companies spend more than $70 billion a year on business intelligence software, according to HG Insights, yet research from BARC and Eckerson Group found only about a quarter of employees actively use BI tools. A 2016 meta-analysis of 138 studies published in Psychological Bulletin found that monitoring progress helps people achieve their goals, with greater benefits when progress is recorded or shared publicly. Getting dashboards onto shared screens can mean relying on manual screenshots, leaving account credentials on devices or publishing sensitive reports publicly.

With OptiSigns, companies connect their dashboard accounts once, pick a dashboard and assign it to one screen or many. The apps work with cloud and self-hosted platforms, personal or company accounts, and any number of teams. In Power BI, a single report can also show each location its own figures. For example, a retailer can use screen-specific filters to display each store's sales figures while managing one report centrally.

Dashboards rotate in playlists, run on schedules or share a split screen like any other OptiSigns content. Screens never hold the account's password or long-lived secrets, which stay encrypted on OptiSigns' servers.

"When the numbers are on the wall, everyone sees the same picture at the same time," said Henry Le, chief executive officer at OptiSigns. "Companies put real money into their dashboards, and then those dashboards sit on a few laptops. We made it simple to get that information in front of the whole team."

Dashboard apps are available today on the Pro Plus plan and higher. Plans start at $10 per screen per month. For more information, visit optisigns.com.

About OptiSigns

OptiSigns is a Houston, Texas-based digital signage company that helps more than 36,000 businesses run content across over 200,000 screens worldwide. Its catalog of 160+ apps turns any TV into a live display for menus, schedules, social feeds and dashboards. Learn more at optisigns.com.

Media Contact: General Media, [email protected]

SOURCE OptiSigns

Share this article

Sixth consecutive year, "Hall of Fame" leader and one of the 2026 Best Companies for Women in India

Additional recognition among the Top 10 for Workplace Wellness and repeats as a Champion of Inclusion

BOCA RATON, Fla. and BENGALURU, India, Oct. 7, 2026 /PRNewswire/ -- Omega Healthcare, an AI-driven healthcare solutions company, has been recognized in three categories of the 2026 Avtar & Seramount benchmarking studies, among India's largest and most rigorous assessments of workplace inclusion and wellness. Omega Healthcare was named a winner in the following listings and will receive the awards at Avtar's Best Practices of the Best conference on Nov. 3.

- Best Companies for Women in India (BCWI) –  BCWI Hall of Fame

Honored for the sixth consecutive year as one of the Best Companies for Women in India, emphasizing the company's focus on creating a workplace where women are empowered to thrive. Omega Healthcare was also included in the BCWI Hall of Fame, a distinction reserved for organizations earning this ranking for five or more years.

- Most Inclusive Companies Index (MICI) – Champions of Inclusion

Highlighted as a Champion of Inclusion for the second consecutive year, recognizing the company's continued efforts to build a culture where diverse perspectives and experiences are welcomed and valued.

- Best Companies for Workplace Wellness (BCWW) – Top 10 Best Companies

Featured as one of the 2026 Top 10 Best Companies for Workplace Wellness, celebrating the company's commitment to employee well-being.

"Recognition across these prestigious benchmarks reinforces our belief that our success is strengthened by incorporating diverse perspectives, building a culture that emphasizes belonging, and prioritizing employee well-being," said Anurag Mehta, CEO and Co-Founder, Omega Healthcare. "This achievement belongs to every employee actively championing inclusivity across the organization. We will continue investing in our people and remain committed to fostering an environment where everyone can succeed, contribute meaningfully, and grow together as 'One Omega.'"

"These distinctions are important because they validate the culture we are consciously building at Omega Healthcare – one where people feel included, supported and empowered to do their best work," said Lalitha M. Shetty, Vice President of Human Resources, Omega Healthcare. "Being recognized across all three categories in the same year is a significant achievement for our company because it reflects consistency in our commitment to our people. For us, inclusion, well-being and opportunity are not standalone initiatives or campaigns; they are an integral part of how we build our workplace and our business. Most importantly, these awards reflect not only what we say about our culture, but how our employees experience it – and that is what motivates us to keep raising the bar."

"Hearty congratulations to our winning companies, and thank you to every organization that participated," said Dr. Saundarya Rajesh, Managing Director of Avtar Group. "The Avtar & Seramount benchmarking process is a valuable opportunity to look honestly at where we are and where we can do better. Companies that invest deliberately in employee well-being are also more likely to show stronger representation and retention. Wellness and inclusion are not separate agendas; they reinforce each other."

Avtar & Seramount's 2026 Best Companies for Women in India, now in its 11th edition, celebrates organizations that are taking meaningful steps to create workplaces where women can build careers, take on leadership and thrive. The Most Inclusive Companies Index evaluates initiatives spanning gender, generational, disability, LGBTQ+ and regional/cultural inclusion. Wellness honorees were selected for how deeply well-being is embedded in their systems, leadership behaviors and culture, rather than for programs alone.

View the complete 2026 listings on the Avtar & Seramount benchmarking studies page.

About Omega Healthcare

Founded in 2003, Omega Healthcare Management Services® (Omega Healthcare) is an AI-driven healthcare solutions company that partners across the healthcare ecosystem to deliver breakthrough results by reimagining and elevating revenue operations. Powered by the Omega Digital Platform®, our agentic AI engine leverages adaptive intelligence to drive automation, complemented by deep human expertise to help optimize performance and deliver sustained financial and clinical outcomes – while enhancing patient satisfaction.

Omega Healthcare empowers organizations across provider, payer, and life sciences sectors to navigate today's healthcare challenges while building the agility to adapt as healthcare and technology continue to evolve rapidly. Recognized by industry analysts, Omega Healthcare has consistently been ranked a leader in driving operational performance excellence.

For more information, visit www.omegahms.com.

About Avtar Career Creators Limited

Avtar Career Creators Limited, founded in 2000 by Dr Saundarya Rajesh, is one of India's leading workplace culture consulting firms, supporting hundreds of companies in creating diverse and high-performing workplaces. An ISO 20700 certified firm, Avtar is credited with introducing the concepts of Diversity, Equity and Inclusion (DEI) to Indian corporates. Avtar is also the country's largest provider of second career opportunities for women, and promotes inclusive hiring through MyAvtar, India's first job portal for underrepresented professionals. As the earliest firm in India to provide end-to-end inclusion solutions, Avtar's services span a broad spectrum, including culture diagnostics, inclusion enablement trainings, conferences & events and culture-first hiring solutions. To know more, visit www.avtarcc.com.

About Seramount

Seramount is a global workforce and talent solutions firm that helps leaders turn insight into action. Built on four decades of research, we partner with more than 600 organizations worldwide to align workforce strategy with business priorities. Through advisory services, benchmarking, assessment and strategy, and early talent solutions, we help organizations achieve measurable impact. To know more, visit www.seramount.com.

Media contacts:

Marykate Reese, [email protected]

[email protected]

SOURCE Omega Healthcare

Share this article

Pharmacy-focused sites are opening in select communities to help increase access to pharmacy care

WOONSOCKET, R.I., Oct. 7, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today unveiled its first pharmacy-focused CVS Pharmacy® in the Boston area. The new pharmacy, located at 32 Warren Street in Roxbury, will help bridge gaps in pharmacy care, and make it easier for community members to access medications, immunizations and other health care services provided by pharmacists.

Nearly 20 pharmacy-focused pharmacy locations will open in select communities across the country in 2026, increasing access to vital pharmacy care. Each site will feature a full-service pharmacy with a customized selection of over-the-counter products available for purchase. Patients who would like to purchase items that are not offered at the pharmacy-focused locations can order additional items with free delivery to their home.

With footprints averaging around 3,000 square feet, the pharmacy-focused locations will help ensure patients have access to prescription medications and the trusted advice and counsel of their neighborhood CVS pharmacist.

"We are reimagining how pharmacy care is delivered by creating locations designed around the needs of the communities we serve," said Sid Tenneti, Senior Vice President and Interim President, Pharmacy and Consumer Wellness, CVS Health. "This new Roxbury pharmacy expands access to medications, immunizations and trusted pharmacist expertise, while reinforcing our commitment to helping people achieve better health in their own neighborhoods."

The new Roxbury pharmacy also offers a safe medication disposal bin for patients wanting to safely dispose of unneeded, unwanted, or expired medications, and is also a safe needle collection site, giving community members a convenient place to safely dispose of used sharps.

Multiple pharmacy formats to meet community health needs

The new pharmacy-focused locations are just one component of the company's work to reinvent pharmacy. By adopting a customized approach focused on the diverse needs of the communities they serve, CVS Pharmacy has worked to strategically realign its retail footprint over the last few years. The new pharmacies will help the company better support its patients in those communities, ensuring its footprint is the right size and scale, and addressing shifts in the pharmacy industry. 

These smaller neighborhood pharmacies join several other formats already in place across the country. They include CVS Pharmacy's traditional full-service front store and pharmacy locations, store-in-store pharmacies, such as those inside Target and Schnucks grocery stores, CVS Pharmacy stores that feature a MinuteClinic retail medical clinic, and side-by-side CVS Pharmacy and Oak Street Health care centers.

The company has opened pharmacy-focused locations in Birmingham, AL, Chicago, IL, Detroit, MI, Houston, TX, and Washington, D.C. The company also plans to open more than 40 new CVS Pharmacy locations this year, including traditional stores and pharmacies in Target.

Importance of one-on-one interactions with pharmacists

The 2025 CVS Health® Rx Report highlighted that 80% of patients prefer face-to-face pharmacy care, and nearly half (48%) would switch pharmacies if limited to digital-only options. The overwhelming majority of pharmacy professionals (97%) also say in-person interactions remain vital. 

"Being able to speak with a pharmacist one-on-one, having questions answered and getting advice and counsel when needed is crucial to helping patients maintain and achieve their best health," said Marco Mares, Pharmacy Manager, CVS Pharmacy. "Our new Roxbury pharmacy is excited to welcome residents, build new relationships and serve the community's pharmacy care needs."

Whether a patient prefers the convenience of prescription delivery or prefers to visit their local pharmacy in-person, CVS Pharmacy is ensuring patients have multiple care options to choose from, depending on their individual needs.

About CVS Health

CVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of June 30, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members. The Company also serves an estimated 37 million people through a broad range of health insurance products and related services. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

Media contacts 

Amy Thibault

401-318-2865 

[email protected]  

Roslyn Guarino

781-974-3962

[email protected] 

SOURCE CVS Health

Share this article

DELRAY BEACH, Fla., Oct. 7, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Active Pharmaceutical Ingredients (API) Market is projected to reach USD 199.42 billion by 2031 from USD 149.02 billion in 2026, at a CAGR of 6.0% during the forecast period.

Browse 747 market data tables and 61 figures spread through 544 pages and an in-depth TOC on "Active Pharmaceutical Ingredients (API) Market - Global Forecast to 2031"

Active Pharmaceutical Ingredients (API) Market Size & Forecast:

- Market Size Available for Years: 2026–2031

- 2026 Market Size: USD 149.02 billion

- 2031 Projected Market Size: USD 199.42 billion

- CAGR (2026–2031): 6.0%

Active Pharmaceutical Ingredients (API) Market Trends & Insights:

- North America accounted for the largest share, 43.1%, of the active pharmaceutical ingredients (API) market in 2025. This dominance is driven by the presence of established pharmaceutical and API manufacturers, strong pharmaceutical R&D activities, increasing demand for innovative and complex medicines, and growing investments in domestic pharmaceutical manufacturing and supply chain resilience.

- Traditional APIs accounted for the largest share of 78.3% of the active pharmaceutical ingredients (API) market in 2025. This dominance is driven by their widespread use in generic and branded medicines, established manufacturing capabilities, broad applications across therapeutic areas, and consistent demand for pharmaceutical products.

- Pharmaceutical companies accounted for the largest share of 45.5% of the active pharmaceutical ingredients (API) market in 2025. This dominance is driven by rising pharmaceutical production, growing demand for APIs for drug development and manufacturing, increasing investment in research and development, and the growing development of innovative and complex medicines.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263

The market is driven by the increasing demand for complex APIs, including high-potency APIs, peptides, and oligonucleotides, supported by the growing need for innovative and specialized pharmaceutical therapies. In addition, government incentives and supply chain reshoring initiatives are encouraging investments in domestic API manufacturing capabilities and strengthening supply security. The increasing adoption of advanced manufacturing technologies and the rising demand for APIs used in novel drug formulations are further supporting market growth. The growing pharmaceutical and biotechnology industries, coupled with the increasing need for effective treatments for chronic and complex diseases, are also contributing to the expansion of API manufacturing and consumption worldwide.

The API market has witnessed significant technological and manufacturing advancements that are reshaping the pharmaceutical manufacturing landscape. The adoption of continuous manufacturing has enabled API producers to improve process efficiency, enhance quality control, and achieve more consistent production, while advanced process analytical technologies are enabling real-time monitoring of critical manufacturing parameters. The increasing use of artificial intelligence, automation, and digital process optimization is further supporting predictive process control, quality management, and operational efficiency. In addition, the development of modular and high-containment manufacturing facilities is enabling manufacturers to handle complex and highly potent APIs more safely and efficiently. Regulatory initiatives are also supporting the adoption of advanced manufacturing technologies, with the US FDA promoting technologies such as continuous manufacturing, distributed manufacturing, and AI through its advanced manufacturing programs. These developments are encouraging API manufacturers to invest in advanced production capabilities while improving manufacturing flexibility, product quality, and supply-chain resilience.

By synthesis, the synthetic APIs segment held the largest share of the active pharmaceutical ingredients (API) market in 2025.

By synthesis, the active pharmaceutical ingredients (API) market is segmented into synthetic APIs and biotech APIs. In 2025, synthetic APIs accounted for the largest market share of 78.6%. This is primarily due to the widespread use of synthetic APIs in the production of generic and innovative medicines across various therapeutic areas. The established manufacturing infrastructure, well-developed synthesis processes, and broad applicability of synthetic APIs across small-molecule drug development further support the dominance of this segment in the market.

By drug, the prescription drugs segment held the largest share of the active pharmaceutical ingredients (API) market in 2025.

By drug, the active pharmaceutical ingredients (API) market is segmented into prescription drugs and over-the-counter drugs. In 2025, prescription drugs accounted for the largest market share of 89.9%. This is primarily due to the widespread use of prescription medicines for the treatment of chronic and complex diseases, including oncology, diabetes, cardiovascular diseases, and other therapeutic conditions. The increasing prevalence of chronic diseases, growing demand for innovative and specialized medicines, and rising pharmaceutical research and development activities further support the dominance of the prescription drugs segment in the market.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=263

By region, North America accounted for the largest share of the active pharmaceutical ingredients (API) market in 2025.

In 2025, North America held the largest share of the active pharmaceutical ingredients (API) market, accounting for 43.1% of the global market. This is supported by a well-established pharmaceutical industry, the presence of major pharmaceutical and API manufacturers, increasing demand for innovative and complex medicines, and strong investments in domestic pharmaceutical manufacturing. The US leads the region in pharmaceutical research & development, advanced drug development, and production of high-value and complex APIs. The presence of major pharmaceutical companies, contract manufacturing organizations, and specialized API manufacturers continues to drive demand for API products. Ongoing investments in advanced manufacturing technologies, domestic production capabilities, and supply chain resilience are further supporting market growth in North America.

Key Players

Leading players in the Active Pharmaceutical Ingredients companies include Pfizer (US), Divi's Laboratories Limited (India), Asymchem (China), Cipla (India), and Evonik (Germany), among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=263

Active Pharmaceutical Ingredients (API) Market - Investment & funding +Merger & Acquisition

Investment Funding Context

The active pharmaceutical ingredient (API) market is witnessing increasing investment, driven by efforts to strengthen pharmaceutical supply chains, expand domestic manufacturing, and build capabilities for complex and high-value drug substances. Investment activity is increasingly focused on capacity expansion, advanced synthesis, high-potency APIs, peptides, and supply-chain localization. For instance, in August 2025, AbbVie (US) announced a USD 195 million investment to expand API manufacturing at its North Chicago facility, supporting current and next-generation medicines across neuroscience, immunology, and oncology. Similarly, in October 2025, Cambrex (US) announced a USD 120 million investment to expand API manufacturing capacity and strengthen peptide manufacturing capabilities in the US. Government initiatives are also supporting investments in critical APIs, KSMs, and drug intermediates. These developments highlight the growing strategic importance of localized, scalable, and technologically advanced API manufacturing.

Revenue Shift Context

The active pharmaceutical ingredient (API) market is witnessing a gradual revenue shift from high-volume, commoditized APIs toward higher-value products such as high-potency APIs (HPAPIs), peptide APIs, complex small molecules, and specialty APIs. The global API market is projected to increase from USD 149.02 billion in 2026 to USD 199.42 billion by 2031, at a CAGR of 6.0%, with a growing share of revenue expected from complex and differentiated drug substances. Conventional generic APIs continue to represent an important revenue base; however, oncology APIs, highly potent compounds, peptides, and APIs requiring specialized manufacturing technologies are gaining greater commercial importance. Increasing pharmaceutical R&D activity, growth in biologics and targeted therapies, supply-chain localization, and outsourcing to specialized API manufacturers and CDMOs are further shifting revenue toward higher-value, technically complex API manufacturing services.

Mergers and Acquisitions

Mergers and acquisitions in the active pharmaceutical ingredient (API) market are being driven by the need to broaden API portfolios, strengthen complex chemistry and manufacturing capabilities, expand geographic presence, and improve access to high-growth areas such as high-potency APIs (HPAPIs), peptide APIs, specialty APIs, and advanced intermediates.

ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET: MERGERS AND ACQUISITIONS, JANUARY 2023–AUGUST 2026

Company Revenue Share Details

The top five players collectively account for approximately 2.8–3.7% of the global active pharmaceutical ingredients (API) market, indicating a highly fragmented and competitive landscape. This reflects the presence of numerous global and regional API manufacturers, specialty API suppliers, CDMOs, and pharmaceutical companies with captive API manufacturing capabilities. Key market participants include Pfizer (US), Divi's Laboratories Limited (India), Asymchem (China), Cipla (India), and Evonik (Germany).

Four-Year Agreement Delivers Nearly 70 Percent Wage Increases for Workers

LOS ANGELES, Oct. 7, 2026 /PRNewswire/ -- More than 500 US Foods drivers, warehouse workers, and mechanics represented by Teamsters Locals 87, 542, 630, 848, and 986 have voted overwhelmingly to ratify a strong new contract. This agreement sets a new standard in the food service industry.

"We strategized, organized, and mobilized our members into action," said Lou Villalvazo, Secretary-Treasurer of Local 630. "This contract reflects the commitment and dedication our members invested in making US Foods the success it is and it rewards their hard work and long hours away from their families."

The group won wage increases averaging between 66 and 70 percent over the life of the agreement, automation language that protects their work, increased pension contributions, and maintained their fully employer-paid health insurance.

"This contract negotiation was not an easy feat," said Kevin Burrow, a 40-year US Foods worker and shop steward with Local 630. "But we never backed down and got the job done. Thanks to our leadership and their hard work, our families and co-workers are going to really benefit from this deal."

US Foods is one of the largest and most profitable food service distributors in the country. The Teamsters represent more than 5,500 US Foods workers nationwide. US Foods Teamsters under this agreement deliver to customers across Southern California, supplying hundreds of local restaurants, major universities, and critical hospital systems.

"This is one of the strongest contracts ever secured in this industry," said Tom Erickson, Director of the Teamsters Warehouse Division. "Teamsters continue to raise the standard and set a powerful example for workers taking on Corporate America nationwide. We will not stop until every company follows suit and recognizes the value of the workers who make its profits possible."

Founded in 1903, the International Brotherhood of Teamsters represents 1.3 million hardworking people in the U.S., Canada, and Puerto Rico. Visit Teamster.org for more information. Follow us on X @Teamsters and on Facebook at Facebook.com/teamsters.

Contact:

Lena Melentijevic, (347) 208-2279

[email protected]

SOURCE International Brotherhood of Teamsters

Share this article

New appointments advance project delivery, operational excellence and investment in people

DURHAM, N.C., Oct. 7, 2026 /PRNewswire/ -- Cypress Creek Energy today announced three strategic executive appointments, building on significant company momentum and supporting its next phase of growth: Peter Toomey has transitioned to Chief Operating Officer, Nancy Bucher has joined as Chief People Officer, and Billy Wang has joined as Executive Vice President of Cypress Creek Solutions. The new hires and assignments reflect Cypress Creek's commitment to its team and to building the leadership and operational capabilities to support continued growth.

A leading U.S. energy infrastructure platform, Cypress Creek develops, finances, owns, and operates utility-scale and distributed energy infrastructure – including solar, storage, and firm capacity solutions. The appointments support the company's accelerating growth as it continues to deliver reliable, affordable power for utilities, communities and large-load customers, including the expanding digital economy.

The company's momentum and ability to execute at scale are reflected in its Steel River Energy Center in Arkansas. Earlier this year, Cypress Creek closed $3.5 billion in financing for Steel River and began construction on the project's first two phases, marking the groundbreaking of America's largest solar project with battery energy storage. Google has secured energy from both phases through a power purchase agreement with Cypress Creek, representing the largest solar and storage project in Google's global portfolio to date.

As Cypress Creek grows, it is investing in the people and culture behind that progress, bringing in new expertise, creating opportunities for its current team and elevating proven leaders.

Peter Toomey, Chief Operating Officer, previously served as Chief Development Officer and has been with Cypress Creek for nearly four years. He has helped drive the success of its development and construction management organizations and shape the company's broader business strategy. As COO, Toomey brings together Project Execution and Cypress Creek Solutions, the company's asset management and operations arm, with additional responsibility for Continuous Improvement and Grid Integration. His appointment aligns critical capabilities across construction, operations and long-term asset performance to support disciplined execution, operational excellence and continued growth.

Nancy Bucher, Chief People Officer, has joined to lead talent acquisition, team member development, total rewards and culture initiatives. Previously Executive Vice President of Human Resources at Golin Ketchum (formerly Golin), she brings experience helping organizations navigate growth and change. Her focus is on attracting great talent, supporting career growth and strengthening the culture that enables Cypress Creek's people to do their best work.

Billy Wang, Executive Vice President of Cypress Creek Solutions, joins Cypress Creek with decades of experience in complex operating environments and performance optimization. He will report to the COO and lead the company's asset management, performance engineering and in-house operations and maintenance platform, whose team manages more than 8.6 GW of energy assets for Cypress Creek and third-party owners across 24 states.

Cypress Creek's long-term ownership and in-house operations capabilities distinguish its approach in the industry. Because the company operates what it builds, lessons from the field feed directly into development, engineering and construction, improving project design, strengthening accountability and maximizing long-term performance.

"We're delivering energy infrastructure at gigawatt scale, and our experienced and focused team makes that possible," said Kevin Smith, CEO of Cypress Creek Energy. "I'm delighted to welcome Nancy and Billy and congratulate Peter on his new role. Together, they will help us build on what makes Cypress Creek special: talented people who care deeply about doing energy the right way, guided by our values, a commitment to safety and strong partnerships with our customers and communities."

About Cypress Creek Energy

Cypress Creek Energy is a U.S. independent power producer and developer of energy infrastructure designed to meet the nation's rapidly growing demand for reliable, cost-effective, and sustainable electricity. Built on more than a decade of experience developing, financing, owning, and operating energy assets, the company delivers integrated solar, storage, and firm capacity solutions that serve utilities, communities, and large-load customers.

Cypress Creek believes energy infrastructure should create lasting value beyond generating affordable, sustainable electricity. Through responsible development, long-term ownership, and meaningful community partnerships, the company is committed to strengthening the places where it lives, works, and builds. Since inception, Cypress Creek has commercialized 19 GW of projects and today has more than 6.8 GW of assets operating or under construction, along with a 19 GW development pipeline. Through Cypress Creek Solutions, its in-house operations and maintenance platform, their experienced team manages more than 8.6 GW of energy assets for both Cypress Creek and third-party owners across 24 states.

Share this article

MAUMEE, Ohio, Oct. 7, 2026 /PRNewswire/ -- Dana Incorporated (NYSE: DAN) will release its 2026 third-quarter financial results on Wednesday, October 28, 2026. A press release will be issued at approximately 7 a.m. EDT, followed by a conference call and webcast at 9 a.m. EDT. Members of the company's senior management team will be available at that time to discuss the results and answer related questions.

The conference call can be accessed by telephone from both domestic and international locations using the information provided below:

Conference ID: 596 110 089

Participant Toll-Free Dial-In Number: +1 833-461-5787

Participant Toll Dial-In Number: +1 585-542-9983

Audio streaming and slides will be available online via a link provided on the Dana investor website: www.dana.com/investors.

A webcast replay can be accessed via Dana's investor website following the call.

About Dana Incorporated

Dana Incorporated (NYSE: DAN) is a global leader in the design and manufacture of highly efficient propulsion solutions for the light- and commercial‑vehicle markets. Guided by its vision to be the world's best powertrain company, Dana delivers advanced conventional and clean‑energy technologies that help customers improve the performance, efficiency, and durability of their vehicles. The company supplies leading vehicle manufacturers and related aftermarkets with industry‑defining drive systems, electrodynamic technologies, and thermal and sealing solutions.

Headquartered in Maumee, Ohio, USA, Dana reported sales of $7.5 billion in 2025. With a history dating to 1904, the company employs 27,000 people in 24 countries across six continents. Learn more at dana.com.

SOURCE Dana Incorporated

Share this article